AI-driven diagnostic solution for early monitoring of chemotherapy effectiveness in lung cancer patients. Utilizes predictive analytics to assess treatment response at early stages, enabling clinicians to optimize therapeutic decisions and improve patient outcomes.
Manufactured by
CheMOnitor Ltd.
Veszprém, Hungary
CheMOnitor Ltd. is a medical device manufacturer that has developed the first early diagnostic solution designed to monitor the effectiveness of chemotherapy in lung cancer patients. The company focuses on providing early-stage monitoring capabilities to assess chemotherapy treatment outcomes for improved patient care.
© 2026 Suplivia · Home · Browse Products